NAV
$89.39
AUM
$38.1B
Expense Ratio
-
Dividend Yield
2.03%
Beta
0.90
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +6.87% | +2.55% | +6.65% | +15.74% | +16.90% | +9.23% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 3.97% |
| 2 | HSBA.L | HSBC Holdings PLC | 2.04% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.87% |
| 4 | NOVN.SW | Novartis AG Registered Shares | 1.83% |
| 5 | AZN.L | AstraZeneca PLC | 1.76% |
| 6 | NESN.SW | Nestle SA | 1.65% |
| 7 | SHEL.L | Shell PLC | 1.52% |
| 8 | SIE.DE | Siemens AG | 1.46% |
| 9 | SAP.DE | SAP SE | 1.18% |
| 10 | SAN.MC | Banco Santander SA | 1.16% |
The fund employs an indexing investment approach designed to track the performance of the FTSE Developed Europe All Cap Index, a market-capitalization weighted index that is made up of common stocks of companies located in European countries. Under normal circumstances, the fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the stocks that make up the target Index.
Inception Date: 2005-03-04